Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Med Chem ; 209: 112947, 2021 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-33139112

RESUMO

Compounds with excellent receptor engagement displaying α2-AR antagonist activity are useful not only for therapeutic purposes (e.g. antidepressants), but also to help in the crystallization of this particular GPCR. Therefore, based on our broad experience in the topic, we have prepared eighteen di-aryl (phenyl and/or pyridin-2-yl) mono- or di-substituted guanidines and 2-aminoimidazolines. The in vitro α2-AR binding affinity experiments in human brain tissue showed the advantage of a 2-aminoimidazolinium cation, a di-arylmethylene core, a conformationally locked pyridin-2-yl-guanidine and a di-substituted guanidinium to achieve good α2-AR engagement. After different in vitro [35S]GTPγS binding experiments in human prefrontal cortex tissue, it was possible to identify that compounds 7a, 7b and 7c were α2-AR partial agonist, whereas 8h was a potent α2-AR antagonist. Docking and MD studies with a model of α2A-AR and two crystal structures suggest that antagonism is achieved by compounds carrying a di-substituted guanidine which substituent occupy a pocket adjacent to TM5 without engaging S2005.42 or S2045.46, and a mono-substituted cationic group, which favorably interacts with E942.65.


Assuntos
Antagonistas de Receptores Adrenérgicos alfa 2/síntese química , Antidepressivos/síntese química , Guanidina/síntese química , Antagonistas de Receptores Adrenérgicos alfa 2/farmacologia , Animais , Antidepressivos/farmacologia , Encéfalo , Desenho de Fármacos , Guanidina/farmacologia , Guanidinas/química , Guanosina 5'-O-(3-Tiotrifosfato)/metabolismo , Humanos , Imidazolinas/química , Modelos Moleculares , Ligação Proteica , Relação Estrutura-Atividade
2.
Nat Commun ; 6: 10140, 2015 Dec 17.
Artigo em Inglês | MEDLINE | ID: mdl-26673816

RESUMO

Diacylglycerol kinase catalyses the ATP-dependent conversion of diacylglycerol to phosphatidic acid in the plasma membrane of Escherichia coli. The small size of this integral membrane trimer, which has 121 residues per subunit, means that available protein must be used economically to craft three catalytic and substrate-binding sites centred about the membrane/cytosol interface. How nature has accomplished this extraordinary feat is revealed here in a crystal structure of the kinase captured as a ternary complex with bound lipid substrate and an ATP analogue. Residues, identified as essential for activity by mutagenesis, decorate the active site and are rationalized by the ternary structure. The γ-phosphate of the ATP analogue is positioned for direct transfer to the primary hydroxyl of the lipid whose acyl chain is in the membrane. A catalytic mechanism for this unique enzyme is proposed. The active site architecture shows clear evidence of having arisen by convergent evolution.


Assuntos
Membrana Celular/enzimologia , Diacilglicerol Quinase/química , Escherichia coli/enzimologia , Trifosfato de Adenosina/química , Trifosfato de Adenosina/metabolismo , Sítios de Ligação , Domínio Catalítico , Membrana Celular/química , Cristalografia por Raios X , Diacilglicerol Quinase/genética , Diacilglicerol Quinase/metabolismo , Escherichia coli/química , Escherichia coli/genética , Modelos Moleculares , Conformação Proteica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...